Category: Clinical Nutrition
Asia Clinical Nutrition
-
Hormone Replacement Therapy Market, by Therapy Type (Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, and Testosterone Replacement Therapy), by Route of Administration (Oral, Parenteral, and Others), by Application (Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, Menopause, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Hypogonadism, Growth Hormone Deficiency, Menopause, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and ... Read More
-
Global Peptide and Anticoagulant Drugs Market, By Route of Administration (Parenteral, Oral, Mucosal, Others), By Product (Hormonal, Antibiotic, ACE Inhibitor, Antifungal, and Others), By Application (Diabetes, Infectious Product, Cancer, Osteoporosis, Cardiology, and Gynecology), By End-User (Hospitals, Clinics, Homecare, and Others), By Region (North America, Europe, The Asia Pacific, Latin America, and The Middle East and Africa)Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... (Hospitals, Clinics, Homecare, and Others), By Region (North America, Europe, The Asia Pacific, Latin America, and The Middle East and Africa)Trend Analysis, Competitive Market Share & Forecast, 2018-2028 Global Peptide and Anticoagulant Drugs Market to ... Read More
-
Acute Bacterial Skin and Skin Structure Infections Market, by Drug Type (Oral & Parenteral Antibiotics {Vancomycin, Linezolid, Clindamycin, Ceftaroline, Daptomycin, Dalbavancin, Tedizolid, and Others (Rifampin, Doxycycline, Minocycline, and Trimethoprim-Sulfa Methoxazol, among others)}, and Topical Antibiotics {Hydrogen Peroxide, Fusidic Acid, Mupirocin, Retapamulin, and Povidone-Iodine}), by Infection Type (Hospital Acquired ABSSSI, and Community Acquired ABSSSI), by Route of Administration (Oral, Parenteral, and Topical), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... {Hydrogen Peroxide, Fusidic Acid, Mupirocin, Retapamulin, and Povidone-Iodine}), by Infection Type (Hospital Acquired ABSSSI, and Community Acquired ABSSSI), by Route of Administration (Oral, Parenteral, and Topical), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online ... Read More
-
Pyrimethamine Market, by Indication (Toxoplasmosis, Malaria, and Others), by Route of Administration (Parenteral and Oral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Europe, Asia
... Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Pyrimethamine is a medicine used to treat protozoan infections. Pyrimethamine belongs to a class of drugs known as antiparasitics. It works ... Read More
-
Clinical Nutrition Market, By Product Type (Infant Nutrition, Enteral Nutrition, Parenteral Nutrition), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific,
... - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Clinical nutrition products are aimed at maintaining a nutritional balance in patients, by providing sufficient amounts of nutrients, such as vitamins, proteins, and minerals. The ... Read More
-
Middle East and Turkey Chronic Liver Disease (CLD) Therapeutics Market, by Disease Type (Hepatitis, Alcohol Induced Liver Disease, Liver Cancer, Fatty Liver Disease, and Others), by Drug Class (Chemotherapy Drugs, Targeted therapy, Vaccines, Immunoglobulin, and Others), by Route of Administration (Oral and Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Country (Turkey, Saudi Arabia, Israel, UAE, Egypt, and Rest of Middle East and Turkey) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Others), by Route of Administration (Oral and Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Country (Turkey, Saudi Arabia, Israel, UAE, Egypt, and Rest of Middle East and Turkey) - ... Read More
-
Parenteral Nutrition Market Size, Share & Trends Analysis Report By Nutrient Type (Trace Elements, Single-dose Amino Acid Solution, Parenteral Lipid Emulsion), By Region (North America, APAC), And Segment Forecasts, 2022 - 2030
... according to a new report by Grand View Research, Inc. Growing incidences of chronic diseases, such as cancer, diabetes, and other neurological conditions; surge in essential nutrition deficiency among critically ill patients; and growing awareness ... Read More
-
Asia Pacific Clinical Nutrition Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... factors attributing to the growth of the Asia Pacific clinical nutrition market include an increase in the prevalence of metabolic disorders and neurological diseases, a rise in the geriatric population in the Asia Pacific Region ... Read More
-
India Enteral Feeding Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... increase in the premature birth rate, increasing adoption of enteral nutrition, and the high prevalence of chronic diseases. Key Highlights The burden of chronic diseases is growing in India. According to the World Health Organization ... Read More
-
Asia-Pacific Enteral Feeding Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... factors that are responsible for the growth of the market include increasing population of geriatrics, higher immature births, growing adoption of enteral nutrition, and higher prevalence of chronic diseases. Difficulties in nutrition and digestion are ... Read More
-
China ulcerative colitis market, by Drug Therapy (5-Aminosalicylates, Monoclonal Antibodies, Steroids, Immunomodulators, and Antibiotics), by Route of Administration (Oral and Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... and Opportunity Analysis, 2021 - 2028 Ulcerative colitis is the most common type of inflammatory bowel disease that affects the colon (lining of the large intestine) and rectum. The inflammation produces tiny sores called ulcers. ... Read More
Research Assistance
